Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, Follicular × vandetanib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 10 Carcinoma, Medullary 9 Thyroid Neoplasms 7 Lung Neoplasms 6 Neoplasm Metastasis 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Carcinoma, Renal Cell 3 Prostatic Neoplasms 2 Kidney Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Familial medullary thyroid carcinoma 2 Fallopian Tube Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid cancer, medullary 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Oligodendroglioma 1 Multiple Endocrine Neoplasia Type 2b 1 Multiple Endocrine Neoplasia Type 2a 1

Interventions

Rituximab 117 Cyclophosphamide 67 fludarabine phosphate 43 Whole-Body Irradiation 34 Mycophenolic Acid 31 Peripheral Blood Stem Cell Transplantation 28 Tacrolimus 26 Etoposide 25 Busulfan 23 Filgrastim 22 Lenalidomide 21 Prednisone 20 Cyclosporine 20 Melphalan 19 Bortezomib 19 Antilymphocyte Serum 19 Methotrexate 18 Vincristine 17 obinutuzumab 15 fludarabine 14 Doxorubicin 14 Bendamustine Hydrochloride 14 Dexamethasone 13 pembrolizumab 12 ibrutinib 12 Radiotherapy 12 Granulocyte Colony-Stimulating Factor 12 Cytarabine 12 Cord Blood Stem Cell Transplantation 12 Carmustine 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡